HK1223393A1 - 安慰劑對照質挑戰方法 - Google Patents

安慰劑對照質挑戰方法

Info

Publication number
HK1223393A1
HK1223393A1 HK16108468.8A HK16108468A HK1223393A1 HK 1223393 A1 HK1223393 A1 HK 1223393A1 HK 16108468 A HK16108468 A HK 16108468A HK 1223393 A1 HK1223393 A1 HK 1223393A1
Authority
HK
Hong Kong
Prior art keywords
placebo
gluten challenge
challenge method
controlled
controlled gluten
Prior art date
Application number
HK16108468.8A
Other languages
English (en)
Inventor
Robert P Anderson
Patrick Griffin
Original Assignee
Immusant Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immusant Inc filed Critical Immusant Inc
Publication of HK1223393A1 publication Critical patent/HK1223393A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK16108468.8A 2013-03-14 2016-07-18 安慰劑對照質挑戰方法 HK1223393A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361785295P 2013-03-14 2013-03-14
PCT/US2014/027101 WO2014152233A1 (en) 2013-03-14 2014-03-14 Placebo-controlled gluten challenge method

Publications (1)

Publication Number Publication Date
HK1223393A1 true HK1223393A1 (zh) 2017-07-28

Family

ID=51581154

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108468.8A HK1223393A1 (zh) 2013-03-14 2016-07-18 安慰劑對照質挑戰方法

Country Status (6)

Country Link
US (1) US20160041148A1 (zh)
EP (1) EP2970893A4 (zh)
AU (1) AU2014240046A1 (zh)
CA (1) CA2906044A1 (zh)
HK (1) HK1223393A1 (zh)
WO (1) WO2014152233A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835603B2 (en) 2008-11-30 2014-09-16 Immusant, Inc. Agents for the treatment of celiac disease
EP3043812A1 (en) 2013-09-10 2016-07-20 Immusant Inc. Dosage of a gluten peptide composition
WO2015164721A1 (en) * 2014-04-24 2015-10-29 Immusant, Inc. Methods of diagnosing celiac disease using ip-10
EP3201354A1 (en) * 2014-09-29 2017-08-09 Immusant Inc. Use of hla genetic status to assess or select treatment of celiac disease
CN107531767A (zh) 2014-11-21 2018-01-02 免疫桑特公司 用于在治疗和诊断1型糖尿病中使用的肽
WO2021198884A1 (en) * 2020-03-30 2021-10-07 Rjs Mediagnostix Method and system for diagnosis and management of gastroesophageal diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1572127T4 (da) * 2002-02-14 2014-11-24 Univ Leland Stanford Junior Enzymbehandling af fødevarer til cøliaki
WO2009139887A2 (en) * 2008-05-16 2009-11-19 The Board Of Trustees Of The Leland Stanford Junior University Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue
US8835603B2 (en) * 2008-11-30 2014-09-16 Immusant, Inc. Agents for the treatment of celiac disease

Also Published As

Publication number Publication date
EP2970893A4 (en) 2016-12-14
AU2014240046A1 (en) 2015-10-08
WO2014152233A1 (en) 2014-09-25
US20160041148A1 (en) 2016-02-11
CA2906044A1 (en) 2014-09-25
EP2970893A1 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
GB201314695D0 (en) Method
GB201318465D0 (en) Method
GB201309057D0 (en) Method
GB201316744D0 (en) Method
HK1223393A1 (zh) 安慰劑對照質挑戰方法
GB201316849D0 (en) Method
GB201309928D0 (en) Method
GB201301857D0 (en) Method
GB201313249D0 (en) Method
GB201309654D0 (en) Method
GB201305714D0 (en) Method
GB201301233D0 (en) Method
GB201300409D0 (en) Method
GB201322948D0 (en) Improved formulation
GB201311385D0 (en) Method
GB201301094D0 (en) Method
GB201314054D0 (en) Method
GB201312609D0 (en) Method
GB201311389D0 (en) Method
GB201404235D0 (en) Bakeware
GB201314141D0 (en) P9
AU2013904681A0 (en) Preparation Method
GB201318490D0 (en) Method
GB201317826D0 (en) Method
GB201316878D0 (en) Method